{"id":559649,"title":"Notice: Prescription Drug List (PDL): Multiple additions [2017-04-21] - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-02-15","captureTimestamp":"2026-02-15T02:26:36.849000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notice-prescription-drug-list-multiple-additions-1.html","snippet":"Notice - Prescription Drug List (PDL): Multiple additions April 21, 2017 Our file number: 17-104599-650 The purpose of this Notice of Amendment is to notify the additions of Brexpiprazole, Necitumumab, Pegaspargase, and Vernakalant hydrochloride to the Human and Veterinary…","rawSnapshotUrl":"/api/snapshots/raw/559649","browseUrl":"https://replay.healtharchive.ca/job-6/20260215022636/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notice-prescription-drug-list-multiple-additions-1.html#ha_snapshot=559649","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}